BDR Pharma launches Bdenza 160 mg for treatment of prostate cancer EP News Bureau Mar 1, 2022 Another first time ever launch of Enzalutamide 160 mg in BDR Pharma's basket was awaited by many Indian oncologists
Mankind Pharma and BDR Pharma come together to launch Molulife (Molnupiravir) EP News Bureau Dec 29, 2021 The tie-up is a licensing arrangement where production is by BDR Pharma and marketing, selling, promotion and distribution is by…
BDR Pharmaceuticals launches India’s first generic Midostaurin (MSTARIN) to treat Leukemia EP News Bureau Dec 8, 2021 The drug will be available in the strength of 25 mg
BDR Pharma launches biapenem to treat intra-abdominal, lower respiratory or complicated urinary… EP News Bureau Sep 27, 2021 BIAPENEM is launched under the brand name BIAPEN, in addition to their existing vast range of antibiotics
BDR Pharmaceuticals set to launch maiden generic Cabozantinib to treat metastatic medullary thyroid… EP News Bureau Sep 15, 2021 The company is amongst the first to receive permission from DCGI and launch the drug in India
Mankind Pharma partners with BDR Pharma to distribute Baricitinib in India EP News Bureau Jun 24, 2021 BDR Pharma will be manufacturing and marketing the product under a royalty-free, limited and non-exclusive voluntary licence from…
BDR Pharma launches generic Rucaparib to treat advanced ovarian and prostate cancers EP News Bureau May 27, 2021 Rucaparib is launched under the brand name BDPARIB in two strengths of 200 mg and 300 mg
BDR Pharma signs voluntary licensing agreement with Lilly for baricitinib EP News Bureau May 19, 2021 Lilly had recently announced seven other voluntary license agreements with major drug manufacturers in India for the production of…
BDR Pharma launches generic version of Lenvatinib in India EP News Bureau Oct 21, 2020 It is indicated for the treatment of differentiated thyroid cancer, advanced liver cancer and advanced kidney cancer
BDR Pharma launches Nintenib (Nintedanib) to treat idiopathic pulmonary fibrosis in India EP News Bureau Oct 19, 2020 Nintenib is priced at Rs 750 (100 mg) and INR 900 (150 mg) for a pack of 10 tabs